Evidence map›Paper›PMID 35984488›Full record

ArticleVirchows Archiv : an international journal of pathology2023

Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.

Chang-Tsu Yuan, Ann-Lii Cheng, Hsin-An Hou

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. ALK+ Anaplastic Large Cell Lymphoma Diagnosed on Paediatric Pericardial Effusion Cytology.Cytopathology : official journal of the British Society for Clinical Cytology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chang-Tsu YuanGraduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Ann-Lii ChengDepartment of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Hsin-An HouDivision of Hematology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, No.7, Chung Shan S. Rd, Zhongzheng Dist, 100225, Taipei City, Taiwan. hsinanhou@ntu.edu.tw.
National Taiwan University Hospital · TW

Funding

National Taiwan University Cancer Center NTUCCS-111-11
6 · The paper itself

Abstract

Effusion-based lymphomas arising from pleural cavities are mostly B cell lymphomas. Non-B cell origins are very rare. These non-B cell lymphomas are usually disseminated and aggressive, and their underlying genetic changes are indeterminate. Here, we reported the first case of primary effusion anaplastic large cell lymphoma (ALCL) with exclusive involvement of a single body cavity, indolent initial presentation, and IRF4/DUSP22 rearrangement. This 73-year-old man had been in his usual health until he presented with exertional dyspnea for 1 month. Physical examination and whole-body imaging indicated isolated left pleural effusion without lymphadenopathies or tumors. Thoracentesis revealed anaplastic large lymphoid cells that were CD30 + , CD3 - , CD8 + , TIA1 + , CD138 - , Epstein-Barr virus-encoded small RNA - , human herpesvirus 8 - , and ALK - . Fluorescence in situ hybridization exhibited IRF4/DUSP22 rearrangement. A primary effusion ALK-negative ALCL was diagnosed. There was no evident progression without chemotherapeutics until 4 months after the diagnosis. Our findings expanded the spectrum of effusion-based lymphoma. Recognition of this disease could prevent misdiagnosis and guide treatment strategies for patients.

Indexed as

Epstein-Barr Virus InfectionsLymphoma, B-CellLymphoma, Large-Cell, AnaplasticAgedDisease ProgressionDual-Specificity PhosphatasesHerpesvirus 4, HumanHumansIn Situ Hybridization, FluorescenceInterferon Regulatory Factor-4MaleMitogen-Activated Protein Kinase PhosphatasesReceptor Protein-Tyrosine KinasesDual-Specificity PhosphatasesDUSP22 protein, humanInterferon Regulatory Factor-4Mitogen-Activated Protein Kinase PhosphatasesReceptor Protein-Tyrosine KinasesALKAnaplastic large cell lymphomaEffusion-based lymphomaHHV8IRF4/DUSP22Primary effusion lymphoma

Identifiers

PMID35984488
OpenAlexW4293817258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.